The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

[CINP2024] Poster Session

CINP2024 » Poster Session

Addiction Disorders 1 - Clinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

[P005] Examining Lurasidone Efficacy in Schizophrenic Patients with Comorbid Alcohol and Substance Use Disorder: A Multicentric Prospective Investigation

STEFANIA CHIAPPINI1, *CLARA CAVALLOTTO2, GIACOMO D'ANDREA2, ANDREA DI CESARE2, ALESSIO MOSCA2, FRANCESCO DI CARLO2, MAURO PETTORRUSO2, GIOVANNI MARTINOTTI2, FABRIZIO SCHIFANO3 (1. UniCamillus, 2. Department of Neuroscience, Imaging and Clinical Science, University G. D'Annunzio, Chieti, Italy, 3. Department of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfeld, UK )

Keywords:dual diagnosis, schizophrenia, psychosis, substance use disorder, addiction

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password